References
- Jensen ML, Schousboe A, Ahring PK. Charge selectivity of the Cys-loop family of ligand-gated ion channels. J Neurochem. 2005;92:217-225. https://doi.org/10.1111/j.1471-4159.2004.02883.x
- Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol. 2007;47:699-729. https://doi.org/10.1146/annurev.pharmtox.47.120505.105214
- Boulter J, Evans K, Goldman D, Martin G, Treco D, Heinemann S, Patrick J. Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit. Nature. 1986;319:368-374. https://doi.org/10.1038/319368a0
- Boulter J, Connolly J, Deneris E, Goldman D, Heinemann S, Patrick J. Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc Natl Acad Sci U S A. 1987;84:7763-7767. https://doi.org/10.1073/pnas.84.21.7763
- Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci. 2002;3:102-114. https://doi.org/10.1038/nrn731
- Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004;74:363-396. https://doi.org/10.1016/j.pneurobio.2004.09.006
- Boorman JP, Groot-Kormelink PJ, Sivilotti LG. Stoichiometry of human recombinant neuronal nicotinic receptors containing the b3 subunit expressed in Xenopus oocytes. J Physiol. 2000; 529:565-577. https://doi.org/10.1111/j.1469-7793.2000.00565.x
- Free RB, McKay SB, Boyd RT, McKay DB. Evidence for constitutive expression of bovine adrenal a3beta4* nicotinic acetylcholine receptors. Ann N Y Acad Sci. 2002;971:145-147. https://doi.org/10.1111/j.1749-6632.2002.tb04450.x
- Di Angelantonio S, Matteoni C, Fabbretti E, Nistri A. Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells. Eur J Neurosci. 2003;17:2313-2322. https://doi.org/10.1046/j.1460-9568.2003.02669.x
- Campos-Caro A, Smillie FI, Domínguez del Toro E, Rovira JC, Vicente-Agulló F, Chapuli J, Juíz JM, Sala S, Sala F, Ballesta JJ, Criado M. Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits. J Neurochem. 1997;68:488- 497.
- Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther. 2002;96:67-202. https://doi.org/10.1016/S0163-7258(02)00298-X
- Speroni E, Minghetti A. Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med. 1988;54:488- 491. https://doi.org/10.1055/s-2006-962525
- Picq M, Cheav SL, Prigent AF. Effect of two flavonoid compounds on central nervous system. Analgesic activity. Life Sci. 1991;49:1979-1988. https://doi.org/10.1016/0024-3205(91)90640-W
- Kandaswami C, Middleton E Jr. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol. 1994;366:351-376.
- Oyama Y, Fuchs PA, Katayama N, Noda K. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2 +)-loaded brain neurons. Brain Res. 1994;635:125-129. https://doi.org/10.1016/0006-8993(94)91431-1
- Harborne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry. 2000;55:481-504. https://doi.org/10.1016/S0031-9422(00)00235-1
- Lee BH, Jeong SM, Lee JH, Kim JH, Yoon IS, Lee JH, Choi SH, Lee SM, Chang CG, Kim HC, Han Y, Paik HD, Kim Y, Nah SY. Quercetin inhibits the 5-hydroxytryptamine type 3 receptor-mediated ion current by interacting with pre-transmembrane domain I. Mol Cells. 2005;20:69-73.
- Lee BH, Lee JH, Yoon IS, Lee JH, Choi SH, Pyo MK, Jeong SM, Choi WS, Shin TJ, Lee SM, Rhim H, Park YS, Han YS, Paik HD, Cho SG, Kim CH, Lim YH, Nah SY. Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2. Brain Res. 2007;1161:1-10.
-
Lee BH, Choi SH, Shin TJ, Pyo MK, Hwang SH, Kim BR, Lee SM, Lee JH, Kim HC, Park HY, Rhim H, Nah SY. Quercetin enhances human
${\alpha}7$ nicotinic acetylcholine receptor-mediated ion current through interactions with$Ca^{2+}$ binding sites. Mol Cells. 2010;30:245-253. -
Lee BH, Choi SH, Shin TJ, Pyo MK, Hwang SH, Lee SM, Paik HD, Kim HC, Nah SY. Effects of quercetin on
${\alpha}9{\alpha}10 $ nicotinic acetylcholine receptor-mediated ion currents. Eur J Pharmacol. 2011;650:79-85. https://doi.org/10.1016/j.ejphar.2010.09.079 - Sine SM, Taylor P. Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. Studies of clonal muscle cells. J Biol Chem. 1982;257:8106-8114.
- Heidmann T, Oswald RE, Changeux JP. Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata. Biochemistry. 1983;22:3112-3127. https://doi.org/10.1021/bi00282a014
- Arias HR. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor. Mol Membr Biol. 1996;13:1-17. https://doi.org/10.3109/09687689609160569
-
Gronlien JH, Ween H, Thorin-Hagene K, Cassar S, Li J, Briggs CA, Gopalakrishnan M, Malysz J. Importance of M2-M3 loop in governing properties of genistein at the
${\alpha}7$ nicotinic acetylcholine receptor inferred from${\alpha}7$ /5-HT3A chimera. Eur J Pharmacol. 2010;647:37-47. https://doi.org/10.1016/j.ejphar.2010.08.027 - Zhang H, Toyohira Y, Ueno S, Shinohara Y, Itoh H, Furuno Y, Yamakuni T, Tsutsui M, Takahashi K, Yanagihara N. Dual effects of nobiletin, a citrus polymethoxy flavone, on catecholamine secretion in cultured bovine adrenal medullary cells. J Neurochem. 2010;114:1030-1038.
- Shinohara Y, Toyohira Y, Ueno S, Liu M, Tsutsui M, Yanagihara N. Effects of resveratrol, a grape polyphenol, on catecholamine secretion and synthesis in cultured bovine adrenal medullary cells. Biochem Pharmacol. 2007;74:1608- 1618. https://doi.org/10.1016/j.bcp.2007.08.013
- Yu BS, Na DM, Kang MY, Lim DY. Polyphenols of Rubus coreanum inhibit catecholamine secretion from the perfused adrenal medulla of SHRs. Korean J Physiol Pharmacol. 2009; 13:517-526. https://doi.org/10.4196/kjpp.2009.13.6.517
- Garcia-Colunga J, Miledi R. Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors. Proc Natl Acad Sci U S A. 1995;92:2919-2923. https://doi.org/10.1073/pnas.92.7.2919
- Garcia-Colunga J, Miledi R. Modulation of nicotinic acetylcholine receptors by strychnine. Proc Natl Acad Sci U S A. 1999;96:4113-4118. https://doi.org/10.1073/pnas.96.7.4113
- Herrero CJ, Garcia-Palomero E, Pintado AJ, Garcia AG, Montiel C. Differential blockade of rat alpha3beta4 and alpha7 neuronal nicotinic receptors by omega-conotoxin MVIIC, omega-conotoxin GVIA and diltiazem. Br J Pharmacol. 1999; 127:1375-1387. https://doi.org/10.1038/sj.bjp.0702692
- Haghighi AP, Cooper E. A molecular link between inward rectification and calcium permeability of neuronal nicotinic acetylcholine alpha3beta4 and alpha4beta2 receptors. J Neurosci. 2000;20:529-541.
- Valera S, Ballivet M, Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A. 1992;89:9949-9953. https://doi.org/10.1073/pnas.89.20.9949
- Kindler CH, Verotta D, Gray AT, Gropper MA, Yost CS. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. Anesthesiology. 2000;92:821-832. https://doi.org/10.1097/00000542-200003000-00026
- Cardoso RA, Brozowski SJ, Chavez-Noriega LE, Harpold M, Valenzuela CF, Harris RA. Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther. 1999;289:774-780.
-
Palma E, Maggi L, Miledi R, Eusebi F. Effects of
$Zn^{2+}$ on wild and mutant neuronal alpha7 nicotinic receptors. Proc Natl Acad Sci U S A. 1998;95:10246-10250. https://doi.org/10.1073/pnas.95.17.10246
Cited by
- TREK-1 채널에 대한 플라보노이드의 효과 vol.12, pp.6, 2011, https://doi.org/10.5762/kais.2011.12.6.2660
- TREK2-채널 과발현 세포주에서 에피갈로카테킨-3-갈레이트의 세포 증식 억제 효과 vol.17, pp.3, 2011, https://doi.org/10.5762/kais.2016.17.3.127
- Potential Therapeutic Targets of Quercetin and Its Derivatives: Its Role in the Therapy of Cognitive Impairment vol.8, pp.11, 2019, https://doi.org/10.3390/jcm8111789